Double-Strand Break Repair Gene Polymorphisms and Risk of Breast or Ovarian Cancer

Deficiencies in DNA repair have been hypothesized to increase cancer risk and excess cancer incidence is a feature of inherited diseases caused by defects in DNA damage recognition and repair. We investigated, using a case-control design, whether the double-strand break repair gene polymorphisms RAD51 5′ untranslated region −135 G > C, XRCC2 R188H G > A, and XRCC3 T241M C > T were associated with risk of breast or ovarian cancer in Australian women. Sample sets included 1,456 breast cancer cases and 793 age-matched controls ages under 60 years of age, 549 incident ovarian cancer cases, and 335 controls of similar age distribution. For the total sample and the subsample of Caucasian women, there were no significant differences in genotype distribution between breast cancer cases and controls or between ovarian cancer cases and combined control groups. The crude odds ratios (OR) and 95% confidence intervals (95% CI) associated with the RAD51 GC/CC genotype frequency was OR, 1.10; 95% CI, 0.80-1.41 for breast cancer and OR, 1.22; 95% CI, 0.92-1.62 for ovarian cancer. Similarly, there were no increased risks associated with the XRCC2 GA/AA genotype (OR, 0.98; 95% CI, 0.76-1.26 for breast cancer and OR, 0.93; 95% CI, 0.69-1.25 for ovarian cancer) or the XRCC3 CT/TT genotype (OR, 0.92; 95% CI, 0.77-1.10 for breast cancer and OR, 0.87; 95% CI, 0.71-1.08 for ovarian cancer). Results were little changed after adjustment for age and other measured risk factors. Although there was little statistical power to detect modest increases in risk for the homozygote variant genotypes, particularly for the rare RAD51 and XRCC2 variants, the data suggest that none of these variants play a major role in the etiology of breast or ovarian cancer.

[1]  J. Boice,et al.  Breast cancer in women with scoliosis exposed to multiple diagnostic x rays. , 1989, Journal of the National Cancer Institute.

[2]  S. Eisenberg,et al.  A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[3]  A. Mattsson,et al.  Excess breast cancer risk and the role of parity, age at first childbirth and exposure to radiation in infancy , 2001, British Journal of Cancer.

[4]  D. Easton,et al.  ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. , 1998, American journal of human genetics.

[5]  F. Pettersson,et al.  Malignant disease after radiation treatment of benign gynaecological disorders. A study of a cohort of metropathia patients. , 1990, Acta oncologica.

[6]  G. Giles,et al.  The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[7]  J L Kelsey,et al.  Radiation and other environmental exposures and breast cancer. , 1993, Epidemiologic reviews.

[8]  V. Siskind,et al.  Reproductive and other factors and risk of epithelial ovarian cancer: An australian case‐control study , 1995, International journal of cancer.

[9]  A. Spurdle,et al.  The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancer , 2001, Molecular carcinogenesis.

[10]  Nicklas Raun Jacobsen,et al.  No association between the DNA repair gene XRCC3 T241M polymorphism and risk of skin cancer and breast cancer. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[11]  G. Giles,et al.  Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). , 1999, Journal of the National Cancer Institute. Monographs.

[12]  Nazneen Rahman,et al.  Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations , 2002, Nature Genetics.

[13]  R. Barakat,et al.  Diagnostic x-rays and risk of epithelial ovarian carcinoma in Jews. , 2002, Annals of epidemiology.

[14]  Jeremy M. Stark,et al.  Variant XRCC3 implicated in cancer is functional in homology-directed repair of double-strand breaks , 2002, Oncogene.

[15]  H. Kato,et al.  Malignant and benign ovarian neoplasms among atomic bomb survivors, Hiroshima and Nagasaki, 1950-80. , 1987, Journal of the National Cancer Institute.

[16]  O. Kallioniemi,et al.  A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. , 2002, American journal of human genetics.

[17]  H. Norppa,et al.  Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. , 2003, Carcinogenesis.

[18]  K. Lohman,et al.  DNA-repair genetic polymorphisms and breast cancer risk. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  R. Parshad,et al.  Deficient DNA repair capacity, a predisposing factor in breast cancer. , 1996, British Journal of Cancer.

[20]  R. Doll,et al.  Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. , 1987, British Journal of Cancer.

[21]  J. Sambrook,et al.  Dominant negative ATM mutations in breast cancer families. , 2002, Journal of the National Cancer Institute.

[22]  I. Andrulis,et al.  Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  A. Cox,et al.  A naturally occurring mutation in an ATP-binding domain of the recombination repair gene XRCC3 ablates its function without causing cancer susceptibility. , 2003, Human molecular genetics.

[24]  K. Miyagawa,et al.  XRCC3 deficiency results in a defect in recombination and increased endoreduplication in human cells , 2004, The EMBO journal.

[25]  L. Parker,et al.  DNA repair gene polymorphisms, pre-natal factors and the frequency of somatic mutations in the glycophorin-A gene among healthy newborns. , 2004, Mutation research.

[26]  D. Hunter,et al.  Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses' Health Study. , 2003, Carcinogenesis.

[27]  Paul D P Pharoah,et al.  Variants in DNA double-strand break repair genes and breast cancer susceptibility. , 2002, Human molecular genetics.

[28]  K. Lohman,et al.  Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. , 2003, Cancer letters.

[29]  Anna Jakubowska,et al.  Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[30]  D. Livingston,et al.  In search of the tumour-suppressor functions of BRCA1 and BRCA2 , 2000, Nature.

[31]  T. Stephenson,et al.  A potential role for the XRCC2 R188H polymorphic site in DNA-damage repair and breast cancer. , 2002, Human molecular genetics.

[32]  L. Bierut,et al.  Genetic and environmental contributions to alcohol dependence risk in a national twin sample: consistency of findings in women and men , 1997, Psychological Medicine.